We are live on ! Find out more
AEMD icon

Aethlon Medical

11 hedge funds and large institutions have $437K invested in Aethlon Medical in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

616% more capital invested

Capital invested by funds: $61K → $437K (+$376K)

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

83% more funds holding

Funds holding: 611 (+5)

0% more ownership

Funds ownership: 0%0% (+0%)

Holders
11
Holders Change
+5
Holders Change %
+83.33%
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
1
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q1 2020 in Review

11 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2020, worth a combined $437K — up 616% from $61K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new AEMD positions and 2 closed out — a net gain of 5 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, adding an estimated $237K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $23K sold.

  • 11 institutional investors held Aethlon Medical (AEMD) as of Q1 2020, up from 6 in Q4 2019.
  • Funds reported $437K of Aethlon Medical stock for Q1 2020, up 616% quarter-over-quarter.
  • 7 funds opened new Aethlon Medical positions in Q1 2020 and 2 closed out, a net change of +5 holders.
  • The largest Aethlon Medical buyer in Q1 2020 was Vanguard Group, an estimated $237K added.
  • The largest Aethlon Medical seller in Q1 2020 was Renaissance Technologies, an estimated $23K sold.

Based on aggregated 13F filings for Q1 2020.